Nordestgaard Liv Tybjærg, Tybjærg-Hansen Anne, Nordestgaard Børge G, Frikke-Schmidt Ruth
Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.
The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, DK-2730 Herlev, Denmark.
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2310-2320. doi: 10.1210/jc.2017-00195.
Recently, data on 2,000,000 people established that low body mass index (BMI) is associated with increased risk of dementia. Whether this observational association reflects a causal effect remains to be clarified.
We tested the hypothesis that there is a causal association between low BMI and high risk of Alzheimer's disease.
DESIGN, SETTING, AND PARTICIPANTS: Using a Mendelian randomization approach, we studied 95,578 individuals from the Copenhagen General Population Study (CGPS) with up to 36 years of follow-up and consortia data on 303,958 individuals from the Genetic Investigation of Anthropometric Traits (GIANT) and the International Genomics of Alzheimer's Project (IGAP).
Risk of Alzheimer's disease.
The causal odds ratio for a 1-kg/m2 genetically determined lower BMI was 0.98 [95% confidence interval (CI), 0.77 to 1.23] for a weighted allele score in the CGPS. Using 32 BMI-decreasing variants from GIANT and IGAP the causal odds ratio for Alzheimer's disease for a 1-standard deviation (SD) lower genetically determined BMI was 1.02 (95% CI, 0.86 to 1.22). Corresponding observational hazard ratios from the CGPS were 1.07 (95% CI, 1.05 to 1.09) and 1.32 (95% CI, 1.20 to 1.46) for a 1-kg/m2 and a 1-SD lower BMI, respectively.
Genetic and hence lifelong low BMI is not associated with increased risk of Alzheimer's disease in the general population. These data suggest that low BMI is not a causal risk factor for Alzheimer's disease and that the corresponding observational association likely is explained by reverse causation or confounding.
最近,来自200万人的数据表明,低体重指数(BMI)与痴呆症风险增加有关。这种观察到的关联是否反映因果效应仍有待阐明。
我们检验了低BMI与阿尔茨海默病高风险之间存在因果关联的假设。
设计、地点和参与者:采用孟德尔随机化方法,我们研究了哥本哈根普通人群研究(CGPS)中的95578名个体,随访时间长达36年,并研究了来自人体测量性状基因研究(GIANT)和国际阿尔茨海默病基因组计划(IGAP)的303958名个体的联盟数据。
阿尔茨海默病风险。
在CGPS中,对于遗传决定的BMI每降低1kg/m²,加权等位基因分数的因果优势比为0.98 [95%置信区间(CI),0.77至1.23]。使用来自GIANT和IGAP的32个降低BMI的变异,遗传决定的BMI每降低1个标准差(SD),阿尔茨海默病的因果优势比为1.02(95%CI,0.86至1.22)。来自CGPS的相应观察性风险比,对于BMI每降低1kg/m²和每降低1个SD,分别为1.07(95%CI,1.05至1.09)和1.32(95%CI,1.20至1.46)。
遗传因素导致的终生低BMI与普通人群中阿尔茨海默病风险增加无关。这些数据表明,低BMI不是阿尔茨海默病的因果风险因素,相应的观察性关联可能由反向因果关系或混杂因素解释。